Type / Class
Equity / Class A Common Stock, par value $0.0001 per share
Shares outstanding
126M
Number of holders
115
Total 13F shares, excl. options
62.9M
Shares change
+5.97M
Total reported value, excl. options
$176M
Value change
+$16.7M
Put/Call ratio
7.34
Number of buys
68
Number of sells
-56
Price
$2.80

Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q2 2024

145 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q2 2024.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 62.9M shares of 126M outstanding shares and own 49.8% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (11.6M shares), Soleus Capital Management, L.P. (11.5M shares), BlackRock Inc. (5.09M shares), Assenagon Asset Management S.A. (3.98M shares), VANGUARD GROUP INC (3.56M shares), ACADIAN ASSET MANAGEMENT LLC (3.07M shares), DEUTSCHE BANK AG\ (2.5M shares), AQR CAPITAL MANAGEMENT LLC (2.27M shares), DIMENSIONAL FUND ADVISORS LP (2.04M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.75M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.